Pharmaceutical maker Moderna has reported positive clinical trial results for three investigational vaccines that will now move into final-stage research. The immunizations are for norovirus, Epstein-Barr virus and varicella-zoster virus, and their development comes as demand for the company's COVID-19 vaccines is waning.